Cediranib is an Orally Available VEGFR Inhibitor for Kinds of Cancer Research
Cediranib is a tyrosine kinase inhibitor that has shown promise in the treatment of cancer. It works by inhibiting the kinase activity of both C-Raf and B-Raf, leading to downregulation…